Cargando…
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis
Arginase is a metalloenzyme which hydrolyzes L-arginine to L-ornithine and urea. Since its discovery, in the early 1900s, this enzyme has gained increasing attention, as literature reports have progressively pointed to its critical participation in regulating nitric oxide bioavailability. Indeed, ac...
Autores principales: | Rabelo, Luiza A., Ferreira, Fernanda O., Nunes-Souza, Valéria, da Fonseca, Lucas José Sá, Goulart, Marília O. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434223/ https://www.ncbi.nlm.nih.gov/pubmed/26064427 http://dx.doi.org/10.1155/2015/924860 |
Ejemplares similares
-
Oxidative Stress in Rheumatoid Arthritis: What the Future Might Hold regarding Novel Biomarkers and Add-On Therapies
por: da Fonseca, Lucas José Sá, et al.
Publicado: (2019) -
Endothelial arginase II and atherosclerosis
por: Ryoo, Sungwoo, et al.
Publicado: (2011) -
Selective Endothelial Overexpression of Arginase II Induces Endothelial Dysfunction and Hypertension and Enhances Atherosclerosis in Mice
por: Vaisman, Boris L., et al.
Publicado: (2012) -
Arginase Inhibitor in the Pharmacological Correction of Endothelial Dysfunction
por: Pokrovskiy, Mihail V., et al.
Publicado: (2011) -
Development of Novel Arginase Inhibitors for Therapy of Endothelial Dysfunction
por: Steppan, Jochen, et al.
Publicado: (2013)